Eventide Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Eventide Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,370,261	Closed	-$20.8M	–	152
2022 Q2	$20.8M	Sell	1,370,261 -501,351	-27%	-$8.62M	0.44%	68
2022 Q1	$35.2M	Hold	1,871,612	–	–	0.55%	59
2021 Q4	$45.8M	Hold	1,871,612	–	–	0.58%	58
2021 Q3	$59.2M	Buy	+1,871,612	New	+$63.7M	0.78%	41

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Eventide Asset Management's DICE Position: Q3 2022 in Review

Eventide Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2022, closing a stake of 1,370,261 shares — an estimated $20.8M sold.

Eventide Asset Management first reported a position in DICE in Q3 2021 and held it in 4 quarters. The position peaked at $59.2M in Q3 2021. 79 funds tracked by Wall St. Rank hold DICE as of Q3 2022.

Eventide Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Eventide Asset Management sold 1,370,261 DICE Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $20.8M.
Eventide Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Eventide Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $59.2M in Q3 2021.
79 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Eventide Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.